Enforra vs Genomi

Enforra and Genomi are both agent frameworks tracked by AIDiveForge. Below is a side-by-side comparison of pricing, capabilities, platforms, and ownership — sourced from each tool's live website and verified before publishing.

Enforra

Orbit is a harness that wraps AI coding agents — Claude, Codex, Cursor, any JSON-speaking CLI — in a bounded task loop: the agent runs, tests and lint decide whether the work passes, and every run leaves inspectable JSON artifacts whether it succeeds or fails. The evidence trail is the product. You get structured output describing what the agent returned, rubric scoring for task focus and diff signal, and a human-readable progress log. Where it breaks: Orbit does not plan, does not write tasks, and does not decide what to build next — it validates and records what other agents attempt. Teams that need autonomous end-to-end execution will hit that ceiling immediately.

Genomi

The core workflow is four steps: install the agent harness, point it at your raw genome file on disk, build a local SQLite index, then ask questions through whichever AI agent you already run — Claude Code, Cursor, Gemini CLI, Goose, and others are listed as compatible. Pharmacogenomics, carrier status, polygenic risk scores, nutrigenomics, and ancestry PCA projection are all covered through distinct skill modules backed by ClinVar, PharmCAT, PGS Catalog, HPO, GenCC, and 1000 Genomes reference data. The privacy architecture is explicit: raw genome data stays on disk, and only the specific evidence snippets relevant to a query cross the boundary to whatever LLM handles the response. The vendor marks this as experimental and not for clinical use — which means researchers and privacy-conscious individuals exploring personal data are the intended audience, not clinical teams expecting diagnostic-grade output.

Attribute	Enforra	Genomi
Pricing	Free	Free
Free trial	No	No
Open source	Yes	Yes
Has API	No	No
Self-hosted option	Yes	Yes
Platforms	Linux, macOS, cross-platform (Python-based)	Linux, macOS, Windows (Python-based)
Released	—	2024
Pros	Agent-neutral adapter contract, so you can swap Claude for Codex behind the same task harness and compare evaluation JSON directly instead of relying on anecdotal impressions across different sessions. Validation gates block task completion until tests and lint pass, which means a self-healing repository workflow produces proof of fix rather than a diff you still have to manually verify. Durable, structured artifacts on every run — pass or fail — so post-mortem review of why an orbit closed or stalled does not depend on reconstructing terminal output from memory. MIT licensed with no commercial tier, so there is no pricing gate between the demo and production use — audit the full source, fork it, and run it on-premises without a vendor relationship. Deterministic replay demo requires no API key, which means you can inspect the complete validation pipeline and artifact structure before committing any agent credentials or budget.	Local-first data architecture keeps the raw genome file on disk and only sends queried evidence snippets to the LLM, so teams with strict data policies can explore personal genomic data without uploading a single variant to a third-party server. Skill modules cover pharmacogenomics via PharmCAT and ClinPGx, carrier status via ClinVar and HPO, polygenic risk via PGS Catalog, and ancestry via 1000 Genomes PCA — so a researcher doesn't have to stitch together five separate tools and manually reconcile their outputs. Each answer carries source attribution and stated evidence limits, which means you can trace a finding back to ClinVar or GenCC rather than accepting a response with no provenance — a real gap in generic LLM genomic Q&A. Agent-agnostic MCP and skills-host architecture plugs into whichever AI agent a team already runs, so there is no forced migration to a new interface or locked-in model provider. Apache-2.0 open-source license with self-hosted deployment means developers building agent-based genomic analysis tools can inspect, modify, and extend the skill layer without negotiating commercial terms.
Cons	Orbit does not plan. It has no mechanism for decomposing a goal into tasks, prioritizing a backlog, or deciding what to work on — that logic lives entirely in whatever feeds the backlog input. Teams that arrive expecting an autonomous coding loop will need to build or bolt on a separate planning layer before Orbit is useful at all. The agent adapter layer requires each coding agent to speak a JSON contract over CLI. Agents that do not expose a structured CLI output — or whose output format shifts across versions — require a custom adapter. At scale across multiple agents, adapter maintenance becomes its own surface. There is no hosted option, no managed runtime, and no UI beyond the artifact files and the progress markdown. Teams that need a dashboard, alerting, or non-developer review interfaces will build those themselves or move to a commercial agent-ops platform that ships them out of the box.	Installation requires following a source-code setup guide and configuring an AI agent to connect to the harness — non-technical users hit a wall before they ask a single question, and there is no hosted web interface to fall back on. The project is vendor-labeled experimental, which means skill coverage, reference database freshness, and edge-case handling are not production-guaranteed; teams relying on consistent outputs for any regulated or clinical-adjacent workflow will find the absence of validation documentation disqualifying and will move to a certified clinical genomics platform instead. There is no hosted API, so teams building products that need to serve genomic queries to end users must provision and maintain their own infrastructure — at scale, that maintenance burden is not accounted for in the zero-cost licensing. Evidence snippets sent to an external LLM during a query still cross a data boundary, even if the raw genome file stays local; teams operating under strict genomic data agreements need to verify that snippet-level transmission satisfies their compliance posture before deploying, and the tool provides no compliance documentation to support that review.

Bottom line

Enforra and Genomi are closely matched on pricing model, openness, and API availability — pick by feature set and platform support in the table above.

Frequently asked questions

What is the difference between Enforra and Genomi?

Enforra is Free and open source, while Genomi is Free and open source. Compare pricing, free trial, API, platforms, and pros/cons in the table above on AIDiveForge.

Is Enforra better than Genomi?

It depends on your workflow. Use the side-by-side attributes (pricing, open source, API, self-hosted, platforms) to decide. AIDiveForge does not rank a universal winner — we publish verified facts so you can choose.